| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |